US Biomax, Inc.

BCN963

Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases/96 cores, replaced by BCN963a

Microarray Panel:Multiple organ carcinoma microarray, containing 16 types of organ cancer with matched or unmatched adjacent normal tissue (esophagus, stomach, colon, rectum, liver, lung, kidney, breast, uterine cervix, ovary, bladder, lymph node, skin, brain, prostate, pancreas), single or duplicate cores per case
Cores:96
Cases:78
Layout:12 cols × 8 rows
Core Diameter:1 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.


Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
123456789101112 
A Eso Eso Eso Sto Sto Sto Col Col Col Rec Rec Rec  
B Eso Eso Eso Sto Sto Sto Col Col Col Rec Rec Rec  
C Liv Liv Liv Lun Lun Lun Kid Kid Kid Bre Bre Bre  
D Liv Liv Liv Lun Lun Lun Kid Kid Kid Bre Bre Bre  
E Ute Ute Ute Ova Ova Ova Bla Bla Bla Lym Lym Lym  
F Ute Ute Ute Ova Ova Ova Bla Bla Bla Lym Lym Lym  
G Ski Ski Ski Bra Bra Bra Pro Pro Pro Pan Pan Pan  
H Ski Ski Ski Bra Bra Bra Pro Pro Pro Pan Pan Pan Marked point
Legend: Bla - Bladder, Bra - Brain, Bre - Breast, Col - Colon, Eso - Esophagus, Kid - Kidney, Liv - Liver, Lun - Lung, Lym - Lymph node, Ova - Ovary, Pan - Pancreas, Pro - Prostate, Rec - Rectum, Ski - Skin, Sto - Stomach, Ute - Uterine cervix

- Malignant tumor, - Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage II), - Malignant tumor (stage III), - Malignant tumor (stage IIIa), - Malignant tumor (stage IIIb), - Malignant tumor (stage IIa), - Malignant tumor (stage IIb), - Malignant tumor (stage IV), - Malignant tumor (stage Ib), - NAT

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 M 56 Esophagus Squamous cell carcinoma 3 IIa T3N0M0 Malignant
A2 2 M 63 Esophagus Squamous cell carcinoma 3 IIa T3N0M0 Malignant
A3 3 M 63 Esophagus Adenocarcinoma 3 IIa T3N0M0 Malignant
A4 4 M 65 Stomach Adenocarcinoma (sparse) Ib T2N0M0 Malignant
A5 5 M 43 Stomach Adenocarcinoma 3 IIIa T3N1M0 Malignant
A6 6 F 54 Stomach Adenocarcinoma 3 IV T3N1M0 Malignant
A7 7 M 70 Colon Adenocarcinoma 2 III T3N1M0 Malignant
A8 8 M 69 Colon Adenocarcinoma (chronic inflammation of colon mucosa) I T2N0M0 Malignant
A9 9 M 24 Colon Mucinous adenocarcinoma 3 III T3N2M0 Malignant
A10 10 M 48 Rectum Adenocarcinoma 1 II T4N0M0 Malignant
A11 11 F 38 Rectum Adenocarcinoma 3 III T3N2M0 Malignant
A12 12 M 58 Rectum Adenocarcinoma 2 II T4N0M0 Malignant
B1 13 M 56 Esophagus Cancer adjacent normal esophagus tissue (skeletal muscle tissue) of No. 1 NAT
B2 14 M 46 Esophagus Cancer adjacent normal esophagus tissue NAT
B3 15 M 64 Esophagus Cancer adjacent normal esophagus tissue (skeletal muscle tissue) NAT
B4 16 M 48 Stomach Cancer adjacent normal stomach tissue NAT
B5 17 M 43 Stomach Cancer adjacent normal stomach tissue NAT
B6 18 F 54 Stomach Cancer adjacent normal stomach tissue of No. 6 NAT
B7 19 M 70 Colon Cancer adjacent normal colon tissue of No. 7 NAT
B8 20 M 69 Colon Cancer adjacent normal colon tissue of No. 8 NAT
B9 21 F 51 Colon Cancer adjacent normal colon tissue NAT
B10 22 M 48 Rectum Cancer adjacent normal rectum tissue of No. 10 NAT
B11 23 F 38 Rectum Cancer adjacent normal rectum tissue of No. 11 NAT
B12 24 M 58 Rectum Cancer adjacent normal rectum tissue of No. 12 NAT
C1 25 M 56 Liver Hepatocellular carcinoma 2 III T3N0M0 Malignant
C2 26 M 39 Liver Hepatocellular carcinoma 2 II T2N0M0 Malignant
C3 27 M 48 Liver Hepatocellular carcinoma 3 II T2N0M0 Malignant
C4 28 M 62 Lung Adenocarcinoma 3 I T2N0M0 Malignant
C5 29 M 39 Lung Adenocarcinoma 2 I T2N0M0 Malignant
C6 30 M 58 Lung Squamous cell carcinoma 2 I T2N0M0 Malignant
C7 31 F 60 Kidney Clear cell carcinoma 1 II T2N0M0 Malignant
C8 32 M 54 Kidney Clear cell carcinoma 1 I T1N0M0 Malignant
C9 33 F 61 Kidney Clear cell carcinoma 1 I T1N0M0 Malignant
C10 34 F 51 Breast Invasive ductal carcinoma 3 IIIb T4N2M0 Malignant
C11 35 F 46 Breast Invasive ductal carcinoma 2 IIb T3N0M0 Malignant
C12 36 F 52 Breast Invasive ductal carcinoma 2 IIIb T4cN2M0 Malignant
D1 37 M 31 Liver Cancer adjacent normal liver tissue NAT
D2 38 M 61 Liver Cancer adjacent normal liver tissue NAT
D3 39 M 48 Liver Cancer adjacent normal liver tissue (cirrhosis) of No. 27 NAT
D4 40 M 75 Lung Cancer adjacent normal lung tissue NAT
D5 41 M 39 Lung Cancer adjacent normal lung tissue (hyperplasia of stroma) of No. 29 NAT
D6 42 M 58 Lung Cancer adjacent normal lung tissue of No. 30 NAT
D7 43 F 50 Kidney Cancer adjacent normal kidney tissue NAT
D8 44 M 54 Kidney Cancer adjacent normal kidney tissue of No. 32 NAT
D9 45 F 61 Kidney Cancer adjacent normal kidney tissue of No. 33 NAT
D10 46 F 51 Breast Cancer adjacent normal breast tissue (fibrous tissue and blood vessel) NAT
D11 47 F 46 Breast Cancer adjacent normal breast tissue of No. 35 NAT
D12 48 F 39 Breast Cancer adjacent normal breast tissue NAT
E1 49 F 48 Uterine cervix Squamous cell carcinoma 2 Ib T1bN0M0 Malignant
E2 50 F 59 Uterine cervix Squamous cell carcinoma 2 Ib T1bN0M0 Malignant
E3 51 F 32 Uterine cervix Squamous cell carcinoma 2 IIIa T3aN0M0 Malignant
E4 52 F 48 Ovary Serous adenocarcinoma 2 I T1N0M0 Malignant
E5 53 F 58 Ovary Serous adenocarcinoma 2 IIIa T3aN0M0 Malignant
E6 54 F 55 Ovary Serous adenocarcinoma 2 I T1N0M0 Malignant
E7 55 M 66 Bladder Transitional cell carcinoma 2 II T2N0M0 Malignant
E8 56 M 42 Bladder Transitional cell carcinoma 2 II T2aN0M0 Malignant
E9 57 M 76 Bladder Transitional cell carcinoma 2 II T3aN0M0 Malignant
E10 58 M 36 Lymph node Diffuse B-cell lymphoma of left groin Malignant
E11 59 M 15 Lymph node Diffuse B-cell lymphoma of right submaxillary Malignant
E12 60 M 39 Lymph node B-cell lymphoma of right groin Malignant
F1 61 F 61 Uterine cervix Cancer adjacent normal uterine cervix tissue NAT
F2 62 F 35 Uterine cervix Cancer adjacent normal uterine cervix tissue NAT
F3 63 F 50 Uterine cervix Cancer adjacent normal uterine cervix tissue NAT
F4 64 F 30 Ovary Cancer adjacent normal ovary tissue NAT
F5 65 F 39 Ovary Cancer adjacent normal ovary tissue NAT
F6 66 F 40 Ovary Cancer adjacent normal ovary tissue (fibrous tissue and blood vessel) NAT
F7 67 M 66 Bladder Cancer adjacent normal bladder tissue of No. 55 NAT
F8 68 M 42 Bladder Cancer adjacent normal bladder tissue of No. 56 NAT
F9 69 M 72 Bladder Cancer adjacent normal bladder tissue NAT
F10 70 M 68 Lymph node Cancer adjacent normal lymph node tissue NAT
F11 71 F 53 Lymph node Cancer adjacent normal lymph node tissue NAT
F12 72 M 69 Lymph node Cancer adjacent normal lymph node tissue (sparse) NAT
G1 73 F 84 Skin Squamous cell carcinoma 2 II T2N0M0 Malignant
G2 74 M 69 Skin Squamous cell carcinoma 2 II T3N0M0 Malignant
G3 75 M 72 Skin Squamous cell carcinoma 3 II T2N0M0 Malignant
G4 76 M 18 Brain Astrocytoma 2 Malignant
G5 77 F 43 Brain Astrocytoma 2–3 Malignant
G6 78 M 42 Brain Astrocytoma 2–3 Malignant
G7 79 M 72 Prostate Adenocarcinoma (hyperplasia) II T2N0M0 Malignant
G8 80 M 71 Prostate Adenocarcinoma (Gleason grade: 1 Gleason score: 1+2) 1 II T2N0M0 Malignant
G9 81 M 76 Prostate Adenocarcinoma (Gleason grade: 5 Gleason score: 4+5) 3 III T3N1M0 Malignant
G10 82 F 54 Pancreas Adenocarcinoma 3 Malignant
G11 83 M 59 Pancreas Adenocarcinoma 3 I T2N0M0 Malignant
G12 84 M 73 Pancreas Undifferentiated carcinoma II T3N0M0 Malignant
H1 85 M 64 Skin Cancer adjacent normal skin tissue NAT
H2 86 M 69 Skin Cancer adjacent normal skin tissue of No. 74 NAT
H3 87 F 61 Skin Cancer adjacent normal skin tissue NAT
H4 88 M 68 Brain Cancer adjacent normal brain tissue NAT
H5 89 M 59 Brain Cancer adjacent normal brain tissue NAT
H6 90 F 58 Brain Cancer adjacent normal brain tissue NAT
H7 91 M 35 Prostate Cancer adjacent normal prostate tissue NAT
H8 92 M 70 Prostate Cancer adjacent normal prostate tissue NAT
H9 93 M 78 Prostate Cancer adjacent normal prostate tissue NAT
H10 94 M 44 Pancreas Cancer adjacent normal pancreas tissue NAT
H11 95 M 59 Pancreas Cancer adjacent normal pancreas tissue of No. 83 NAT
H12 96 F 58 Pancreas Cancer adjacent normal pancreas tissue NAT
M 58 Skin Malignant melanoma (tissue marker) Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array: